about
Family-based clusters of cognitive test performance in familial schizophrenia.Mapping quantitative trait loci from a single-tail sample of the phenotype distribution including survival data.Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres.Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland - implications for elimination of transmissionComparative analysis of Streptococcus pneumoniae transmission in Portuguese and Finnish day-care centres.Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage studyMetagenes associated with survival in non-small cell lung cancer.All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine.Efficient Markov chain Monte Carlo implementation of Bayesian analysis of additive and dominance genetic variances in noninbred pedigreesPioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countriesAdvanced backcross-QTL analysis in spring barley (H. vulgare ssp. spontaneum) comparing a REML versus a Bayesian model in multi-environmental field trialsPioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study.Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies.Vaginal estradiol use and the risk for cardiovascular mortality.Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy.Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality.Psychotropic drugs and homicide: A prospective cohort study from Finland.[Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative].Modeling transmission of multitype infectious agents: application to carriage of Streptococcus pneumoniae.Modelling multi-type transmission of pneumococcal carriage in Bangladeshi families.Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy.Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry.Bayesian prediction of breeding values by accounting for genotype-by-environment interaction in self-pollinating crops.Bayesian mapping of genotype x expression interactions in quantitative and qualitative traits.A note on estimating the posterior density of a quantitative trait locus from a Markov chain Monte Carlo sample.Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults.Entacapone and prostate cancer risk in patients with Parkinson's disease.The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort studyCoronary Heart Disease Mortality and Hormone Therapy Before and After the Womenʼs Health InitiativeEntacapone did not Increase Prostate Cancer Risk or Mortality in Patients with Parkinson's DiseasePatients With COPD who Initiate Roflumilast in SwedenRegional Assessment of Severe Hypoglycemic Coma Events in FinlandA semiparametric density estimation approach to pattern classificationOn the estimation error in binned local linear regressionPioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies
P50
Q24800316-F4DAE737-CAC7-426B-AE4B-E2C12ADDB74CQ31139618-978E8753-9CBA-4F14-9E1C-7B8D3910E810Q33396556-544B9F7A-35D5-4EDF-B98D-056B38175148Q33475186-DC4597C7-7BF2-4E50-AFCC-6ACB18F17BA8Q34677165-23C63004-0CEB-4075-A213-EE05DDD71CAAQ34699129-B1C71047-1E96-478B-86B0-86776B1EE1A3Q35055017-5E05DCA0-819F-457E-AEA9-6262BC8F1BEAQ35974970-3D5429C9-3CD7-4F0A-92B0-08774A7699C7Q36724289-3AB2E779-3214-4AE0-8ACA-F89EFEF2BC9FQ37179822-6182A3CF-4544-4D25-A449-8000A6D79B7DQ37371774-92F19BF9-2E66-4AC6-AB72-3C4BD4FE3894Q38650414-F633CE4D-1CF8-4177-99E5-2976272CA311Q38737194-63DC0455-62D2-4794-AD21-26ABE2C7E4DDQ38746077-1D585107-2A79-4710-99D6-E436F305A890Q39771731-CDE6D19F-A762-4363-B73D-EC2E298DFED9Q39999161-E6BEC7F9-5750-4AD5-8F30-A1AAAEC623ACQ40491166-896ED0E2-DAFF-4DDF-A50B-7D4937A4518EQ41171206-37AE7BEC-58B7-41CB-8B5F-F44D7301CE26Q42425130-9C350AEB-7F51-4DEC-8CF8-358FC5DB17E1Q43675105-92FC231D-8D00-4961-9BB3-3C53FE99F80BQ43892077-260E6008-4CC1-4C1F-B637-9B9A314BAB20Q45008990-A2EA59BF-E29C-4874-BE2F-968398E5543FQ47587434-8224B458-AFCB-4768-980B-A0BC271A4DC9Q47647304-ACE628BB-F1E3-4C91-9E82-A337DC00F860Q47823178-76E4C2B4-1B64-471E-9836-B7A317D8DFB4Q51616361-67CB5191-5B95-48EA-85C8-BB5B5C370DD6Q51942549-3370E391-4E3E-4712-B5D3-463ABE6A2781Q52041332-A07C50E7-CACB-458B-A579-495DA26439DCQ53598738-CE811D46-AC2D-4A4A-AC53-76821CA3DF21Q53623137-09C93980-75D2-43EB-A6E3-EE93CE28A2BFQ60644079-0169F7B5-6735-4D52-9195-FF7D5DAC44A1Q60644081-BED9C73B-3D0D-4E92-969C-B4AF4EA4EBDAQ60644082-BD045279-B9E3-4F84-9F74-C3D5D2FAE03BQ60644085-B49AF8A7-DC5B-45A7-B269-B021D368C8A2Q60644087-71A4AE71-93D6-4D60-8205-710DC120F5A5Q60644090-05886E6F-0991-4BF3-822E-37C57AABF69DQ60644091-275169B8-A050-430A-AF97-2909F8CD91B9Q91875408-46171CCE-AC10-446D-B561-69A27161CD8C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabian Hoti
@ast
Fabian Hoti
@en
Fabian Hoti
@es
Fabian Hoti
@nl
Fabian Hoti
@sl
type
label
Fabian Hoti
@ast
Fabian Hoti
@en
Fabian Hoti
@es
Fabian Hoti
@nl
Fabian Hoti
@sl
altLabel
f.j.hoti
@en
prefLabel
Fabian Hoti
@ast
Fabian Hoti
@en
Fabian Hoti
@es
Fabian Hoti
@nl
Fabian Hoti
@sl
P106
P21
P31
P496
0000-0002-7464-3549